OBJECTIVE. The aim of this study was to evaluate a new injection-acquisitio
n technique performed using a multirow detector CT scanner for separation o
f three distinct hepatic circulatory phases (hepatic artery, portal venous
inflow, hepatic venous) and to determine which of these phases is optimal f
or detecting hypervascular neoplasm.
MATERIALS AND METHODS. Two sequential acquisitions were performed during a
single breath-hold followed by a third acquisition beginning 60 sec after i
njection. Injection-to-scan delay for the first acquisition was the individ
ual patient's circulation time, which was determined by a preliminary mini
bolus. The mean attenuation of the upper abdominal aorta, portal vein, and
hepatic parenchyma were determined for each imaging pass in 20 patients wit
h cirrhosis and 20 patients without cirrhosis. Tumor-to-liver contrast for
hypervascular primary and metastatic neoplasm was evaluated in a different
set of 16 cirrhotic patients and nine noncirrhotic patients. Three-dimensio
nal CT arteriograms were obtained from first-pass data.
RESULTS. Three distinct circulatory phases (hepatic artery, portal vein inf
low or late arterial, and hepatic venous) were seen in cirrhotic and noncir
rhotic patients. Maximum tumor-to-liver contrast for hypervascular primary
and metastatic neoplasm occurred during the second pass for both cirrhotic
(p < 0.005) and noncirrhotic (p < 0.001) patients. A three-dimensional hepa
tic-mesenteric CT arteriogram of normal or anomalous hepatic vessels withou
t venous overlay was obtained from first-pass data in all patients.
CONCLUSION. Rapid-sequence hepatic helical CT allows selection of the optim
al time interval fur hypervascular tumor detection. A new paradigm for rapi
d hepatic CT acquisition-namely, hepatic arterial, portal vein inflow, and
hepatic venous phases-is recommended to replace hepatic artery dominant and
portal venous phases.